RU2012118499A - Способ получения пиразинонового ингибитора тромбина и промежуточных соединений для его получения - Google Patents

Способ получения пиразинонового ингибитора тромбина и промежуточных соединений для его получения Download PDF

Info

Publication number
RU2012118499A
RU2012118499A RU2012118499/04A RU2012118499A RU2012118499A RU 2012118499 A RU2012118499 A RU 2012118499A RU 2012118499/04 A RU2012118499/04 A RU 2012118499/04A RU 2012118499 A RU2012118499 A RU 2012118499A RU 2012118499 A RU2012118499 A RU 2012118499A
Authority
RU
Russia
Prior art keywords
difluoro
formula
fluoropyridine
compound
salt
Prior art date
Application number
RU2012118499/04A
Other languages
English (en)
Russian (ru)
Inventor
Регури Бучи РЭДДИ
Уппарапалли САМПАТХКУМАР
Нилам САХУ
Джавваджи Карунакара РАО
Гэйд Брахма РЭДДИ
Original Assignee
Диакрон Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Диакрон Фармасьютикалз, Инк. filed Critical Диакрон Фармасьютикалз, Инк.
Publication of RU2012118499A publication Critical patent/RU2012118499A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00Other general methods

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
RU2012118499/04A 2009-11-03 2010-11-02 Способ получения пиразинонового ингибитора тромбина и промежуточных соединений для его получения RU2012118499A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2663CH2009 2009-11-03
IN2663/CHE/2009 2009-11-03
PCT/US2010/055176 WO2011056806A1 (en) 2009-11-03 2010-11-02 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates

Publications (1)

Publication Number Publication Date
RU2012118499A true RU2012118499A (ru) 2013-12-10

Family

ID=43926105

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012118499/04A RU2012118499A (ru) 2009-11-03 2010-11-02 Способ получения пиразинонового ингибитора тромбина и промежуточных соединений для его получения

Country Status (10)

Country Link
US (1) US8541580B2 (https=)
EP (1) EP2496087A4 (https=)
JP (1) JP2013510159A (https=)
KR (1) KR20120106727A (https=)
CN (1) CN102711481A (https=)
AU (1) AU2010315338A1 (https=)
CA (1) CA2778922A1 (https=)
MX (1) MX2012005165A (https=)
RU (1) RU2012118499A (https=)
WO (1) WO2011056806A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140090663A (ko) 2011-11-07 2014-07-17 디아크론 파마슈티칼스, 인코포레이티드 직접 트롬빈 억제제의 연장 방출성 제형
MX392191B (es) 2015-10-26 2025-03-21 Bayer Cropscience Ag Derivados de heterociclos biciclicos condensados como agentes de control de plagas.
JP7535532B2 (ja) 2019-02-26 2024-08-16 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤としての縮合二環式複素環式誘導体
EP3931193A1 (en) 2019-02-26 2022-01-05 Bayer Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147078A (en) * 1998-05-19 2000-11-14 Merck & Co., Inc. Pyrazinone thrombin inhibitors
UA58636C2 (uk) * 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
EP1341784A2 (en) * 2000-12-06 2003-09-10 Merck & Co., Inc. Process for making a thrombin inhibitor
EP1422221A1 (en) * 2002-11-20 2004-05-26 Bayer CropScience SA Novel process for the preparation of 2-aminomethylpyridine derivative

Also Published As

Publication number Publication date
CA2778922A1 (en) 2011-05-12
EP2496087A4 (en) 2013-06-19
CN102711481A (zh) 2012-10-03
WO2011056806A1 (en) 2011-05-12
KR20120106727A (ko) 2012-09-26
AU2010315338A1 (en) 2012-05-24
US20110105753A1 (en) 2011-05-05
MX2012005165A (es) 2012-08-08
EP2496087A1 (en) 2012-09-12
JP2013510159A (ja) 2013-03-21
US8541580B2 (en) 2013-09-24

Similar Documents

Publication Publication Date Title
KR101934096B1 (ko) 이델라리십의 제조방법
RU2012115111A (ru) Способ получения азабициклических соединений
US20130096319A1 (en) Process for preparation of amisulpride
JP2009235096A5 (https=)
RU2015106856A (ru) Способ получения производных пиразолкарбоновой кислоты
RU2012118499A (ru) Способ получения пиразинонового ингибитора тромбина и промежуточных соединений для его получения
RU2011139325A (ru) Аморфная соль макроциклического ингибитора hcv
WO2012129384A2 (en) Compositions and processes of preparing and using the same
JP2012251113A5 (https=)
CN101274915B (zh) 一种合成异噁唑的方法
RU2018130327A (ru) Улучшенный способ получения осимертиниба (azd9291) или его соли и "анилин-azd9291" или его соли
RU2010144309A (ru) Превращение триптофана в производные бета-карболина
JP2013510159A5 (https=)
JP2009504800A5 (https=)
WO2007032019B1 (en) Process for preparing valsartan
US20160251316A1 (en) Process for the preparation of enzalutamide
CA2647457A1 (en) A hydride reduction process for preparing quinolone intermediates
RU2008108089A (ru) Органические соединения
JP2013518093A5 (https=)
US7186860B2 (en) Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
CN101353312B (zh) 苯甘氨酸衍生物的合成
EP2980061A1 (en) Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof
JP5507579B2 (ja) N−[5−(3−ジメチルアミノ−アクリロイル)−2−フルオロ−フェニル]−n−メチル−アセトアミドの調製方法
RU2015108347A (ru) Способ и промежуточные соединения для изготовления дазатиниба
CN110172011A (zh) 一种制备草酰胺酯的方法

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150122